Differences between 'intact' PTH and 1-84 PTH assays in chronic renal failure and dialysis

Pediatric Nephrology

Volumn 20, Issue 2, 2005, Pages 197-199

  Waller, Simon ^a   Ridout, Deborah ^a   Cantor, Tom ^b   Rees, Lesley ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b Scantibodies Laboratory   (United States)

Author keywords

Carboxyl terminal PTH fragments; Immunoradiometric PTH assay; Renal osteodystrophy

Indexed keywords

BIOCHEMICAL MARKER; PARATHYROID HORMONE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BIOASSAY; BONE TURNOVER; CHRONIC KIDNEY FAILURE; CONCENTRATION (PARAMETERS); CONSERVATIVE TREATMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS REACTION; DIALYSIS; FEMALE; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; IMMUNORADIOMETRIC ASSAY; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; LINEAR SYSTEM; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; CHILD; FEMALE; HUMANS; IMMUNOASSAY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; PARATHYROID HORMONE; RENAL DIALYSIS;

EID: 12944281488     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1735-2     Document Type: Article

References (9)

1. Goodman WG, Salusky IB, Juppner H (2002) New lessons from old assays: parathyroid hormone (PTH), its receptors, and the potential biological relevance of PTH fragments. Nephrol Dial Transplant 17:1731-1736 10.1093/ndt/17.10.1731
2. John MR, Goodman WG, Gao P, Cantor TL, Salusky IB, Juppner H (1999) A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: Implications for PTH measurements in renal failure. J Clin Endocrinol Metab 84:4287-4290 10.1210/jc.84.11.4287
3. Tanno Y, Yokoyama K, Nakayama M, Katoh A, Yamamoto H, Iwasaki Y, Cantor T, Fukagawa M, Shigematsu T, Hosoya T (2003) IRMA (whole PTH) is a more useful assay for the effect of PTH on bone than the Allegro intact PTH assay in CAPD patients with low bone turnover marker. Nephrol Dial Transplant 18 [Suppl 3]:97-98
4. Reichel H, Esser A, Roth HJ, Schmidt-Gayk H (2003) Influence of PTH assay methodology on differential diagnosis of renal bone disease. Nephrol Dial Transplant 18:759-768 10.1093/ndt/gfg144
5. Goodman WG, Juppner H, Salusky IB, Sherrard DJ (2003) Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy. Kidney Int 63:1-11 10.1046/j.1523-1755.2003.00700.x
6. Brossard JH, Lepage R, Cardinal H, Roy L, Rousseau L, Dorais C, D'Amour P (2000) Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays. Clin Chem 46:697-703 1:CAS:528:DC%2BD3cXjsVKksbg%3D
7. Waller S, Reynolds A, Ridout D, Cantor T, Gao P, Rees L (2003) Parathyroid hormone and its fragments in children with chronic renal failure. Pediatr Nephrol 18:1242-1248 1:CAS:528:DC%2BD3cXjsVKksbg%3D
8. Salusky IB, Ramirez JA, Oppenheim W, Gales B, Segre GV, Goodman WG (1994) Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 45:253-258 1:STN:280:ByuC2s3psVU%3D
9. Godber IM, Parker CR, Lawson N, Hitch T, Porter CJ, Roe SD, Cassidy MJ, Hosking DJ (2002) Comparison of intact and 'whole molecule' parathyroid hormone assays in patients with histologically confirmed post-renal transplant osteodystrophy. Ann Clin Biochem 39:314-317 10.1258/0004563021902044